TY - JOUR
T1 - A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information
AU - Luo, Yunan
AU - Zhao, Xinbin
AU - Zhou, Jingtian
AU - Yang, Jinglin
AU - Zhang, Yanqing
AU - Kuang, Wenhua
AU - Peng, Jian
AU - Chen, Ligong
AU - Zeng, Jianyang
N1 - Funding Information:
This work was supported in part by the National Natural Science Foundation of China (Grants 61472205 and 81470839), the China’s Youth 1000-Talent Program, the Beijing Advanced Innovation Center for Structural Biology and the Tsinghua University Initiative Scientific Research Program (Grant 20161080086). J.P. is supported by the NSF CAREER Award, the Alfred P. Sloan Research Fellowship and the Pharmaceutical Research and Manufacturers of America Foundation Research starter grant in informatics. We acknowledge the support of NVIDIA Corporation with the donation of the Titan X GPU used for this research. We thank Mr. W. Ding and Dr. H. Gong for their helpful suggestions on our computational docking studies.
Publisher Copyright:
© 2017 The Author(s).
PY - 2017/12/1
Y1 - 2017/12/1
N2 - The emergence of large-scale genomic, chemical and pharmacological data provides new opportunities for drug discovery and repositioning. In this work, we develop a computational pipeline, called DTINet, to predict novel drug-target interactions from a constructed heterogeneous network, which integrates diverse drug-related information. DTINet focuses on learning a low-dimensional vector representation of features, which accurately explains the topological properties of individual nodes in the heterogeneous network, and then makes prediction based on these representations via a vector space projection scheme. DTINet achieves substantial performance improvement over other state-of-the-art methods for drug-target interaction prediction. Moreover, we experimentally validate the novel interactions between three drugs and the cyclooxygenase proteins predicted by DTINet, and demonstrate the new potential applications of these identified cyclooxygenase inhibitors in preventing inflammatory diseases. These results indicate that DTINet can provide a practically useful tool for integrating heterogeneous information to predict new drug-target interactions and repurpose existing drugs.
AB - The emergence of large-scale genomic, chemical and pharmacological data provides new opportunities for drug discovery and repositioning. In this work, we develop a computational pipeline, called DTINet, to predict novel drug-target interactions from a constructed heterogeneous network, which integrates diverse drug-related information. DTINet focuses on learning a low-dimensional vector representation of features, which accurately explains the topological properties of individual nodes in the heterogeneous network, and then makes prediction based on these representations via a vector space projection scheme. DTINet achieves substantial performance improvement over other state-of-the-art methods for drug-target interaction prediction. Moreover, we experimentally validate the novel interactions between three drugs and the cyclooxygenase proteins predicted by DTINet, and demonstrate the new potential applications of these identified cyclooxygenase inhibitors in preventing inflammatory diseases. These results indicate that DTINet can provide a practically useful tool for integrating heterogeneous information to predict new drug-target interactions and repurpose existing drugs.
UR - http://www.scopus.com/inward/record.url?scp=85029583555&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029583555&partnerID=8YFLogxK
U2 - 10.1038/s41467-017-00680-8
DO - 10.1038/s41467-017-00680-8
M3 - Article
C2 - 28924171
AN - SCOPUS:85029583555
VL - 8
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
IS - 1
M1 - 573
ER -